Martine Vercammen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Martine Vercammen has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Linda Broodtaerts
Department of Hematology, Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, Brussels 1090, Belgium
2 shared publicationsPatricia Meirlaen
Department of Hematology, Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, Brussels 1090, Belgium
2 shared publicationsXavier Bossuyt
Laboratory Medicine, Department of Microbiology and Immunology, University Hospitals Leuven and Experimental Laboratory Immunology, KU Leuven, Herestraat 49, Leuven 3000, Belgium
2 shared publicationsAn Verloes
1 shared publicationAnnick Ocmant
1 shared publication- Etienne Waelkens
Laboratory for Protein Phosphorylation and Proteomics, KU Leuven, O & N1 Herestraat 49, P.O. Box 901, 3000 Leuven, Belgium
1 shared publication
Latest Publications
- 1 April 2015
- Published by Elsevier in Clinica Chimica Acta
- Vol. 444, 297-302
Overestimation of free light chain antigen excess rate
- 1 April 2015
- Published by Elsevier in Clinica Chimica Acta
- Vol. 444, 297-302
Overestimation of free light chain antigen excess rate
- 1 January 2012
- Published by Elsevier in Clinica Chimica Acta
- Vol. 413 (1-2) , 105-108
Betaine homocysteine methyl transferase 1, a novel auto-antigen associated with anti-Golgi immune reactivity
- 1 January 2012
- Published by Elsevier in Clinica Chimica Acta
- Vol. 413 (1-2) , 105-108
Betaine homocysteine methyl transferase 1, a novel auto-antigen associated with anti-Golgi immune reactivity
- 1 September 2011
- Published by Elsevier in Clinica Chimica Acta
- Vol. 412 (19-20) , 1798-1804
Effect of sample dilution on serum free light chain concentration by immunonephelometric assay
- 1 September 2011
- Published by Elsevier in Clinica Chimica Acta
- Vol. 412 (19-20) , 1798-1804
Effect of sample dilution on serum free light chain concentration by immunonephelometric assay
- 1 June 2009
- Published by Wolters Kluwer Health in Current Opinion in Obstetrics and Gynecology
- Vol. 21 (3) , 285-290
Can soluble human leucocyte antigen-G predict successful pregnancy in assisted reproductive technology?
To review the predictive value of soluble human leucocyte antigen-G (HLA-G) in embryo culture fluid for implantation, considering origin, structure, function and detection method of soluble HLA-G. Soluble HLA-G in embryo culture supernatant has been proposed as a noninvasive marker for the selection of embryos with implantation potential. Controversially, some centres detect soluble HLA-G in none of the culture supernatants of embryos that evolve towards pregnancy, whereas others report it to be mandatory. According to a recently published meta-analysis, the pooled diagnostic accuracy for predicting clinical pregnancy is low. Factors influencing soluble HLA-G results are numerous, for example, embryo culture (single or multiple, washing/denudation steps, medium, day 2 to 5 sample collection), sample preservation to prevent degradation and HLA-G immunoassays (standard, detection limit, reproducibility). Published studies are very heterogeneous. Moreover, the origin of soluble HLA-G in embryo culture fluid is unresolved. From the embryonic genome activation at day 3 onwards, the embryo should be able to produce HLA-G. Before, it is maternally derived, either from the oocyte, follicular fluid or follicular cells contaminating embryo culture. At present, no studies have been published on the relationship between pregnancy and soluble HLA-G in supernatants from individually cultured and individually transferred embryos using standardized embryo culture and soluble HLA-G immunoassay, sensitive at the picogram level. As such, it remains undetermined whether the pregnancy is induced by an HLA-G-producing embryo. Therefore, the predictive value of soluble HLA-G in embryo culture supernatant for selection of embryos with good implantation potential remains unknown.
- 1 June 2009
- Published by Wolters Kluwer Health in Current Opinion in Obstetrics and Gynecology
- Vol. 21 (3) , 285-290
Can soluble human leucocyte antigen-G predict successful pregnancy in assisted reproductive technology?
To review the predictive value of soluble human leucocyte antigen-G (HLA-G) in embryo culture fluid for implantation, considering origin, structure, function and detection method of soluble HLA-G. Soluble HLA-G in embryo culture supernatant has been proposed as a noninvasive marker for the selection of embryos with implantation potential. Controversially, some centres detect soluble HLA-G in none of the culture supernatants of embryos that evolve towards pregnancy, whereas others report it to be mandatory. According to a recently published meta-analysis, the pooled diagnostic accuracy for predicting clinical pregnancy is low. Factors influencing soluble HLA-G results are numerous, for example, embryo culture (single or multiple, washing/denudation steps, medium, day 2 to 5 sample collection), sample preservation to prevent degradation and HLA-G immunoassays (standard, detection limit, reproducibility). Published studies are very heterogeneous. Moreover, the origin of soluble HLA-G in embryo culture fluid is unresolved. From the embryonic genome activation at day 3 onwards, the embryo should be able to produce HLA-G. Before, it is maternally derived, either from the oocyte, follicular fluid or follicular cells contaminating embryo culture. At present, no studies have been published on the relationship between pregnancy and soluble HLA-G in supernatants from individually cultured and individually transferred embryos using standardized embryo culture and soluble HLA-G immunoassay, sensitive at the picogram level. As such, it remains undetermined whether the pregnancy is induced by an HLA-G-producing embryo. Therefore, the predictive value of soluble HLA-G in embryo culture supernatant for selection of embryos with good implantation potential remains unknown.